EN

News Room

Sep. 24, 2026

EziSurg Medical's easyEndo™ E-Lite Receives FDA Clearance

EziSurg Medical announces that its easyEndo™ E-Lite powered endoscopic stapler has received clearance from the U.S. Food and Drug Administration (FDA), marking an important milestone in the company’s expansion in the United States.


As EziSurg Medical’s first-generation powered endoscopic stapler, E-Lite reflects the company’s commitment to translating surgical needs into practical product design. Its development brings together powered firing, ergonomic handling and features designed to support controlled operation during minimally invasive surgery.


Designed Around Surgical Needs


E-Lite’s “3E” design philosophy—Economic Operation, Ergonomic Design and Enhanced Safety—focuses on supporting surgeons throughout the stapling workflow.


One-touch powered firing reduces reliance on repeated, high-force manual activation, while balanced handling and straightforward controls support ease of use. The platform also incorporates a defined manual recovery mechanism for situations where powered retraction is unavailable.


EziSurg Medical's easyEndo™ E-Lite Receives FDA Clearance


These features reflect a consistent development priority: helping surgeons maintain control through device positioning, firing and completion of the procedure.


Technical Capability Supported by Rigorous Evaluation


Obtaining FDA clearance requires manufacturers to support their submissions with technical evidence addressing applicable safety and performance requirements. For surgical stapling devices, this calls for coordinated work across engineering, testing, risk management and regulatory affairs.


EziSurg Medical's easyEndo™ E-Lite Receives FDA Clearance


E-Lite’s clearance represents a tangible outcome of EziSurg Medical’s sustained investment in product development and verification. It provides a foundation for U.S. market expansion and reinforces the company’s commitment to building its international presence through product quality and technical capability.


Advancing Our Global Presence


FDA clearance marks another milestone in EziSurg Medical’s global development, reflecting the technical expertise and product verification behind easyEndo™ E-Lite. This achievement strengthens the foundation for building confidence among healthcare professionals and distribution partners worldwide.


As EziSurg Medical expands its international presence, the company continues to invest in innovation, product quality and local support. With E-Lite, it aims to bring reliable powered stapling solutions to more surgical teams and build lasting partnerships grounded in product performance and clinical needs.


To learn more about easyEndo™ E-Lite and partnership opportunities, contact contact@ezisurg.com.


Ingenuity, Driving Global Healthcare.


Headquarters (China)

Address

No. 399 Miaoqiao Road, Pudong New District, Shanghai 201315, P.R. China

Phone

+86 400-090-6176

Fax

+86 21-5067-6156

Website

https://en.ezisurg.com

U.S. Subsidiary

Address

Suite 403, 6136 Frisco Square Blvd., Frisco, Texas 75034, USA

Phone

+1 469-252-2118

Or Leave Us a Message, We Will Get Back to You Asap!

Copyright © Ezisurg Medical Co., Ltd. All Rights Reserved. | Sitemap Privacy Policy Terms of Services | Powered by Reanod

WeChat